Matches 1 - 50 out of 118 1 2 3 >


Match Document Document Title
US20140044710 VON WILLEBRAND FACTOR SPECIFIC BINDERS AND METHODS OF USE THEREFOR  
The invention provides new uses for specific binders to the A1 domain of the von Willebrand Factor (vWF), in particular the use in patients with stable angina undergoing elective percutaneous...
US20140065646 ASSAY SYSTEM  
An assay apparatus comprising: i) an assay cartridge (52, 53) comprising at least one well (57-62) and a pipette (50) positionable in at least one said well; ii) a holder arranged to received said...
US20130065256 ASSAY SYSTEM  
An assay apparatus comprising: i) an assay cartridge (52, 53) comprising at least one well (57-62) and a pipette (50) positionable in at least one said well; ii) a holder arranged to received said...
US20120040369 ON-BOARD CONTROL DETECTION  
Embodiments disclosed herein relate to a sensor comprising an on-board control system and a testing system. The on-board system can determine viability of the control system or the testing system....
US20140004613 MULTIPLE COAGULATION TEST CARTRIDGE AND METHOD OF USING SAME  
Embodiments of the present invention relate to multiple coagulation test cartridges and methods of using such cartridges. In one embodiment the cartridge is a disposable single-use cartridge for...
US20150064732 Analytical Test Cartridge; and, Methods  
An analytical test cartridge is provided. The analytical test cartridge can be used for medical analyses of liquid samples removed from a patient, for example blood. The analytical test cartridge...
US20120309035 STABLE SOLUTION  
The present invention relates to a stable solution comprising a stable solution without coagulation factor XII and with a defined amount of ionized calcium. The stable solution may be used as...
US20070249037 Monitoring of Vitamin K Nutritional Status  
Disclosed herein is a diagnostic apparatus for determining the level of certain nutrients in a body fluid sample, which are used by clinicians to assess proper dosages of anticoagulants, such as...
US20090191641 IMMUNODIAGNOSTIC TEST CARDS HAVING INDICATING INDICIA  
An immunodiagnostic test card includes a plurality of transparent chambers wherein each chamber includes a quantity of testing material that combines with a patient sample, when mixed, to produce...
US20120238026 BLOOD COAGULATION SYSTEM ANALYZING METHOD AND BLOOD COAGULATION SYSTEM ANALYZING DEVICE  
A blood coagulation system analyzing method includes acquiring information relating to the coagulability of blood based on a change generated in a complex permittivity spectrum measured in a...
US20140256052 APPARATUS AND METHOD FOR ANALYZING BLOOD CLOTTING  
The invention includes systems, apparatuses and methods to evaluate the strength of clotting in addition to or separate from activated clotting time. The strength of clotting may be correlated...
US20140147875 DISEASE SEVERITY INDEX FOR ASSESSMENT OF CHRONIC LIVER DISEASE AND METHOD FOR DIAGNOSIS OF THREE DISTINCT SUBTYPES OF PRIMARY SCLEROSING CHOLANGITIS  
A Disease Severity Index (DSI) is provided for assessment of chronic liver disease in a patient using non-invasive liver function test results. A DSI was derived from non-invasive liver function...
US20120190052 Method of determining factor XIII by means of NAD(P)H-analogues  
The invention is in the field of in-vitro diagnostics and relates to a photometric method for determining the blood-clotting factor XIII (factor XIII, F XIII) with the aid of NAD(P)H analogues,...
US20130189789 High Range Activated Clotting Time Assay Formulation  
High range activated clotting time (HR-ACT) tests detect blood clotting time in blood samples which have high levels of heparin. Reagents such as calcium chloride and kaolin within the test...
US20140087403 LOW-VOLUME COAGULATION ASSAY  
Compositions and methods for measuring coagulation parameters using very small volumes of blood are provided. Advantageously, the methods described herein can be performed from a single drop of...
US20150253343 PORTABLE COAGULATION MONITORING DEVICES, SYSTEMS, AND METHODS  
Portable coagulation monitoring devices, systems, and methods are disclosed. Namely, a test cartridge is provided for use in a portable coagulation monitor (PCM) device. Further, the test...
US20120129777 Methods for Treating Bleeding Disorders Using Sulfated Polysaccharides  
Methods for treating bleeding disorders using non-anticoagulant sulfated polysaccharides (NASPs) as procoagulants are disclosed. NASPs can be administered as single agents, or in combination with...
US20140155498 Method of Manufacture of Stable Liquid Coagulation Factors  
A diagnostic or therapeutic formulation of stable liquid coagulation factors comprises at least one coagulation factor, at least one stabilizer, and optional additives. The stabilizer is either...
US20110159597 ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASURING REAGENT, ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASURING METHOD, AND DETERMINATION METHOD FOR DETERMINING PRESENCE OR ABSENCE OF BLOOD COAGULATION INHIBITOR  
An activated partial thromboplastin time measuring reagent, comprising a heparin neutralizer is disclosed. An activated partial thromboplastin time measuring method, and a determination method for...
US20140273249 High Range Activated Clotting Time Assay Formulation  
High range activated clotting time (HR-ACT) tests detect blood clotting time in blood samples which have high levels of heparin. Reagents such as calcium chloride and kaolin within the test...
US20110039285 MICROFLUIDIC DEVICE AND METHOD FOR FLUID CLOTTING TIME DETERMINATION  
A microfluidic passive device and a method for determining clotting time are described, of a fluid medium such as blood, of low production cost which can therefore be disposable. When optimised to...
US20070054405 Patient sample classification based upon low angle light scattering  
An apparatus for classifying a liquid patient sample includes at least one sample container having a quantity of a sample that is aggressively acted upon so as to create a flow field. A...
US20080183062 Method of Distinguishing Among Type a and Type B Acute Aortic Dissection and Acute Myocardial Infraction and Kit For Distinguishment  
Provided is a method of distinguishing among Stanford type A acute aortic dissection, Stanford type B acute aortic dissection, and acute myocardial infarction, which are mutually similar in terms...
US20150140560 ASYNCHRONOUS MAGNETIC BEAD ROTATION (AMBR) MICROVISCOMETER FOR ANALYSIS OF ANALYTES  
The disclosure provides a label-free viscosity-based analyte detection system using paramagnetic beads as an asynchronous magnetic bead rotation (AMBR) microviscometer. It is disclosed herein that...
US20070020765 Procedure for the standardization of coagulation tests  
The present invention lies in the field of coagulation diagnosis and relates to a procedure for the standardization of coagulation tests, where calibrators are used to which a discrete standard...
US20120237960 Devices and Methods for Determining the Platelet Function in a Centrifugal Analyzer  
The invention lies in the field of platelet function diagnostics and relates to devices and methods for determining the platelet function in a centrifugal analyzer.
US20110178039 OLIGOSACCHARIDE MIXTURES DERIVED FROM HEPARIN, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM  
Oligosaccharide mixtures comprising anti-Xa activities of from 190 IU/mg to 450 IU/mg and anti-IIa activities of less than 0.2 IU/mg; and having constituent oligosaccharides with an average...
US20110129862 METHOD FOR DETERMINING CAUSE OF THE PROLONGATION OF BLOOD COAGULATION TIME  
Provided is a method of accurately and easily determining a cause of the prolongation of blood coagulation time. The method of determining a cause of the prolongation of blood coagulation time in...
US20140242707 Compositions and Methods for Diagnosing Hypercoagulability and Hypocoagulability  
The present invention provides a method for diagnosing hypercoagulability associated with carbon monoxide exposure in a subject. The method comprises obtaining a plasma sample from the subject,...
US20140106382 CAPILLARY FLUID FLOW MEASUREMENT AND CAPILLARY FLOW DEVICE THEREFORE  
The present invention relates to a liquid flow device, in particular a capillary testing device provided as a chip, comprising a second pathway which intersects the first pathway at a downstream...
US20120052585 REAGENT KIT FOR DETECTING LUPUS ANTICOAGULANT AND METHOD OF DETERMINING PRESENCE OR ABSENCE OF LUPUS ANTICOAGULANT  
The present invention provides a reagent kit for detecting LA which includes a first clotting time-measuring reagent containing manganese salt and a second clotting time-measuring reagent which...
US20130059782 PHOSPHOLIPID-ENRICHED VESICLES BEARING TISSUE FACTOR HAVING HAEMOSTATIC ACTIVITIES AND USES THEREOF  
The invention relates to a method for improving the procoagulant properties of TF expressed in eukaryotic cells by contacting microvesicles derived from said eukaryotic cells with a...
US20130102015 COMPOSITION FOR THE DETERMINATION OF COAGULATION CHARACTERISTICS OF A TEST LIQUID  
The present invention is directed to a diagnostic composition for use in the viscoelastic analysis of a test liquid, and to a container (1) comprising same. The composition comprises at least an...
US20120064552 USING BLOOD CLOT IN MICROFLUIDIC VALVING APPLICATIONS  
The present invention provides a method of forming a blood-clot microvalve by heating blood in a capillary tube of a microfluidic device. Also described are methods of modulating liquid flow in a...
US20110171264 Protein Formulation  
An aqueous composition which comprises a protein or other biological molecule and also (i) optionally comprises one or more metal ions at a concentration of 0.01 to 20 mM; (ii) comprises...
US20150140671 METHOD AND SYSTEM FOR ASSEMBLING A MICROFLUIDIC SENSOR  
A microfluidic sensor (10), such as an electrochemical blood test strip, with more accurate measurement comprises a plurality of channels (24) through which a fluid to be tested flows via a...
US20120220038 REAGENT KIT FOR DETECTING LUPUS ANTICOAGULANT AND METHOD OF DETERMINING PRESENCE OR ABSENCE OF LUPUS ANTICOAGULANT  
In order to provide a reagent kit for detecting LA which can clearly separate a lupus anticoagulant (LA)-positive specimen group from an LA-negative specimen group, it is configured that the...
US20140038214 MICROFLUIDIC FLOW ASSAY AND METHODS OF USE  
A microfluidic-based flow assay and methods of manufacturing the same are provided. Specifically, the microfluidic flow assay includes a substrate surface comprising lipid coated particles and...
US20130164855 METHOD OF MONITORING THROMBUS FORMATION  
A method of monitoring thrombus formation is described, which comprises flowing anticoagulated blood into a thrombus formation chamber, in at least a part of which a thrombus formation inducer...
US20140295472 Paper Based Diagnostic Test  
A device utilizing agglutination and its method of use to diagnose diseases or conditions. The diagnostic device may comprise a substrate having pores, an agglutination zone, and a test readout...
US20150185235 Blood Factor Monitoring Assay and Uses Thereof  
The present disclosure provides methods and compositions for diagnosing and treating subject having a bleeding disorder. The disclosed methods comprise contacting a sample, e.g., a blood or plasma...
US20130202550 NON-ANTICOAGULANT SULFATED OR SULFONATED SYNTHETIC POLYMERS  
The present invention provides pharmaceutical formulations including a non-anticoagulant, non-saccharide polymer that with at least one sulfate or sulfonate moiety. The pharmaceutical formulations...
US20140038299 MICROFLUIDIC DEVICE AND METHOD FOR FLUID CLOTTING TIME DETERMINATION  
A method for determining clotting time is described, of a fluid medium such as blood. This method monitors and compares the propagation of the fluid medium having a regent with a theoretical...
US20080297169 Particle Fraction Determination of A Sample  
The present invention provides a device, test cards, methods and kits which are useful for determining the particle fraction and rate of viscosity of a fluid sample, the presence of an analyte in...
US20130171736 BLOOD COAGULATION DETECTION DEVICE AND METHOD  
A blood coagulation detection device includes a micro channel unit, an optical signal unit, an opto-electronic conversion circuit, an amplifier circuit, and a filter circuit. The micro channel...
US20080153876 Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor  
Unit doses of factor Xa inhibitor compounds and methods of using these compounds for inhibiting blood coagulation in a human patient are taught herein. The unit dose of the factor Xa inhibitor...
US20090275141 Affinity Adsorbents for Factor VIII and Von Willebrand's Factor  
For the separation, removal, isolation, purification, characterisation, identification or quantification of Factor VIII, von Willebrand's Factor or a protein that is a analogue of either, an...
US20140127725 METHOD FOR DETECTING LUPUS ANTICOAGULANTS  
Provided is the development of a convenient LA detection method in which even a sample derived from a patient who receives anticoagulant therapy of warfarin, heparin or the like, is not affected...
US20130344606 Heparin Concentration and Heparin Response Imbalance Determination Method Within a Fluid Containing Heparin  
Provided herein are various methods for determining heparin concentration or heparin response imbalance in native whole blood, citrated whole blood, or plasma by measuring two parameters that...
US20090280570 METHOD FOR TESTING EFFICACY OF ANTITHROMBOTIC AGENT  
The present invention provides a method for testing quickly and easily the manner in which an antithrombotic agent inhibits the acceleration of blood coagulation when a platelet agonist causes...

Matches 1 - 50 out of 118 1 2 3 >